InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-07-02 00:00:00 ET · period of report 2024-07-01 · accession 0001477449-24-000166 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-07-02 2024-07-02 TDOC Nanis Nikolaos P. CTO S - Sale+OE $9.39 -442 73.2K -0.6% -$4,150
D 2024-07-02 2024-07-01 TDOC Nanis Nikolaos P. CTO M - OptEx — +1,233 73.7K +2% —
D 2024-07-02 2024-07-01 TDOC Nanis Nikolaos P. CTO M - OptEx $0.00 -1,233 6,165 -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-07-02 S D 442 $9.39 73,226 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2024-07-01 M A 1,233 — 73,668 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2024-07-01 M D 1,233 $0.00 6,165 D — · — to — 1,233 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.